Several cancer cell lines, particularly under conditions of ACLY deficiency, hypoxia or nutrient limitation, favor this pathway (57, 59), but even under glucose-replete conditions ACSS2 may be preferably used to support de novo lipogenesis, as in case of human cytomegalovirus infection (HMCV) (61). Here, ACSS2 is linked to cancer.